PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
January 14, 2026Journal of Clinical Oncology0 citations

Outcomes of carcinoid syndrome in small versus large intestinal neuroendocrine tumors.

View Full Paper
AAAbdulmalek AljafariRBRami BasmaciEast Carolina UniversityJSJana SatmaEast Carolina University

Key Points

  • This research aims to compare outcomes of carcinoid syndrome in small intestinal versus large intestinal neuroendocrine tumors.
  • Analyzed data from the National Inpatient Sample (2016–2022) on hospitalizations with carcinoid syndrome and neuroendocrine tumors.
  • Focused on comparing clinical characteristics and hospitalization outcomes between small and large intestinal NET patients.
  • Primary outcome assessed was inpatient mortality, with secondary outcomes including length of stay and hospitalization costs.
  • Inpatient mortality was 6.2% overall, with 12.6% in large intestinal NETs compared to 5.3% in small intestinal NETs.
  • Patients with large intestinal NETs had a higher comorbidity burden, reflected by a mean cumulative comorbidity index of 3.2 versus 2.3 for small intestinal NETs.
  • No significant differences in length of stay or hospitalization costs between small and large intestinal NET groups.

Abstract

620 Background: Carcinoid syndrome (CS) most commonly arises from small intestinal neuroendocrine tumors (NETs) due to their high propensity for hepatic metastases, while large intestinal NETs rarely produce CS and usually represent more advanced disease when they do. Whether outcomes differ between small and large intestinal NETs complicated by CS remains poorly defined. We compared clinical characteristics and hospitalization outcomes in patients with CS due to small versus large intestinal NETs using a national dataset. Methods: We queried the National Inpatient Sample (2016–2022) to identify adult hospitalizations with a diagnosis of carcinoid syndrome and malignant NETs of the small or large intestine. The primary outcome was inpatient mortality. Secondary outcomes included length of stay (LOS), hospitalization cost, need for mechanical ventilation, venous thromboembolism, hypovolemic shock, arrhythmias, and cardiac valvular disease. Multivariable logistic regression was performed to assess mortality risk adjusting for age, sex, race, and comorbidity burden. Results: A total of 2, 874 hospitalizations with CS and intestinal NETs were identified; 2, 519 (87. 6%) were small intestine and 355 (12. 4%) were large intestine. Patients with large intestinal NETs had a higher comorbidity burden (mean CCI 3. 2 vs. 2. 3, p=0. 02) but similar age (66. 1 vs. 65. 9 years, p=0. 9) and sex distribution (male 56. 3% vs. 49. 6%, p=0. 2) compared with small intestine NETs. Overall inpatient mortality was 6. 2% (n=179). Mortality was significantly higher in large intestinal NETs compared with small intestinal NETs (12. 6% vs. 5. 3%, p=0. 01). On multivariable analysis, large intestinal NETs with CS had a 156% increased odds of inpatient death compared to small intestinal NETs (adjusted OR 2. 56, 95% CI, p=0. 026). LOS (7. 2 vs. 7. 4 days, p=0. 8) and mean hospitalization costs (92, 980 vs. 108, 034, p=0. 4) were similar between groups. No significant differences were observed in mechanical ventilation, venous thromboembolism, atrial fibrillation/flutter, or hypovolemic shock. No cases of carcinoid heart syndrome, tricuspid stenosis, or pulmonary stenosis were identified. Conclusions: In this national cohort, carcinoid syndrome arising from large intestinal NETs was associated with more than a twofold higher risk of inpatient mortality compared with small intestinal NETs, despite similar demographics and resource utilization. These findings suggest important biological or clinical differences in outcomes by tumor site and highlight the need for further study of risk factors and management strategies in this rare population.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Aljafari et al. (2026) studied this question.

synapsesocial.com/papers/6966f2f013bf7a6f02c00497https://doi.org/10.1200/jco.2026.44.2_suppl.620
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Association of inpatient outcomes with carcinoid syndrome among malignant neuroendocrine tumor hospitalizations in the United States: NIS 2016–2022.2026
  2. 2Demographic and clinicopathological factors impacting survival in malignant carcinoid tumors: A SEER database analysis.2026
  3. 3Survival trends in the management of carcinoid heart disease among patients with neuroendocrine neoplasms2026
  4. 4Oncological Outcomes after Elective and Emergency Resection of Small Intestinal Neuroendocrine Tumours2026 · 1 citations
  5. 5Abstract 1192: Survival trends in the management of carcinoid heart disease among patients with neuroendocrine tumors.2026